NASDAQ$COO

The Cooper Companies Inc · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Briefing

Reported a revenue increase of 15% year-over-year, with strong growth in both CooperVision and CooperSurgical segments.

CooperCompanies announced strong second quarter results with revenue up 15% year-over-year to $829.8 million. Both CooperVision and CooperSurgical showed strong revenue growth. GAAP diluted earnings per share increased to $2.55, while non-GAAP diluted earnings per share decreased to $3.24.

  • Revenue increased 15% year-over-year to $829.8 million.
  • CooperVision revenue was up 6% to $553.8 million.
  • CooperSurgical revenue was up 40% to $276.0 million.
  • GAAP diluted earnings per share increased to $2.55, up from $2.36 last year.

Headline financials

Total Revenue

$830M

Previous: $720M+15.3%
EPS (adj)

$0.81

Previous: $0.85-4.7%
GAAP Gross Margin

64.0%

Previous: 68.0%-5.9%
GAAP Operating Margin

16.0%

Previous: 20.0%-20.0%
Capital Expenditures

-$101M

Previous: -$106M+5.0%
Free Cash Flow

$197M

Previous: $235M-15.9%
Net Income

$127M

Previous: $118M+7.7%
Operating Income

$133M

Previous: $143M-7.3%
Gross Profit

$533M

Previous: $487M+9.3%
Cash & Equivalents

$399M

Previous: $106M+277.0%
Total Assets

$11.8B

Previous: $9.01B+30.7%

Revenue & EPS history

Cooper · Revenue · Quarterly

$830M

Q2 2022+15.3%vs Q2 2021
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Cooper · $276M total across 2 segments · Q2 2022

  • Office and Surgical
    $162M+43.5%
  • Fertility
    $114M+35.7%

Forward guidance

The Company updated its fiscal year 2022 financial guidance.

Tailwinds

  • Fiscal 2022 total revenue $3,280 - $3,312 million (organic growth of 9% to 10%)
  • CVI revenue $2,225 - $2,247 million (organic growth of 10% to 11%)
  • CSI revenue $1,055 - $1,065 million (organic growth of 6% to 7%)
  • Fiscal 2022 non-GAAP diluted EPS $13.09 - $13.29
  • Assumes a 50 basis point rate increase in both June and July and a 25 basis point rate increase in September

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2022

Historical avgQ2 2022

+0.5%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-0.1%

Avg return

30 days after

51%

35 / 68 earnings

Positive

+12.1%

Q3 2024

Best reaction

-12.8%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-4.6%-8.0%-12.5%
Q4 2025-4.3%+4.8%+5.3%
Q3 2025-12.8%-11.8%-8.9%
Q2 2025+0.0%-0.3%+3.6%
Q1 2025-6.6%-13.1%-18.9%
Q4 2024-6.0%-5.6%-12.6%
Q3 2024+12.1%+12.1%+16.4%
Q2 2024+3.5%+3.8%-4.2%
Q1 2024+8.1%+7.3%+7.4%
Q4 2023-2.2%-0.7%+6.8%
Q3 2023-2.1%-3.5%-15.9%
Q2 2023-4.0%-5.1%+3.2%
Q1 2023+8.7%+3.9%+15.4%
Q4 2022-1.6%+4.8%+9.7%
Q3 2022+4.1%+2.5%-8.5%
Q2 2022-0.3%+1.3%-7.2%
Q1 2022+2.1%-8.5%+3.1%
Q4 2021+4.8%+8.7%+12.2%
Q3 2021+1.1%-0.7%-7.6%
Q2 2021-0.7%-3.2%+6.0%
Q1 2021+1.8%+0.3%+1.1%
Q4 2020+3.3%+3.3%+8.6%
Q3 2020+2.0%+0.3%+5.7%
Q2 2020-0.2%-5.0%-9.1%
Q1 2020-1.3%-0.9%-17.3%
Q4 2019-1.6%-2.4%+3.3%
Q3 2019-3.5%-6.7%-8.3%
Q2 2019+4.5%+9.0%+18.2%
Q1 2019-1.8%+0.1%+1.0%
Q4 2018-11.6%-7.3%-10.4%
Q3 2018-3.7%-3.4%+4.3%
Q2 2018+1.4%-0.4%+6.0%
Q1 2018+2.1%-3.8%-11.5%
Q4 2017-3.2%-1.9%-1.5%
Q3 2017-4.0%-2.5%-3.7%
Q2 2017+8.9%+10.5%+9.4%
Q1 2017-3.1%-3.6%-0.4%
Q4 2016+1.3%+4.1%+5.2%
Q3 2016+0.0%+1.3%-3.6%
Q2 2016-0.1%-0.4%+7.1%
Q1 2016+6.4%
Q4 2015-12.8%
Q3 2015-7.1%
Q2 2015-5.1%
Q1 2015+9.7%
Q4 2014-4.4%
Q3 2014+0.7%
Q2 2014+1.7%
Q1 2014+4.3%
Q4 2013-4.6%
Q3 2013-1.8%
Q2 2013+8.1%
Q1 2013+2.5%
Q4 2012+1.0%
Q3 2012+10.3%
Q2 2012-4.1%
Q1 2012+2.8%
Q4 2008+2.8%
Q4 2011+2.8%
Q3 2011-1.8%
Q2 2011+1.4%
Q2 2010+1.4%
Q1 2010+8.9%
Q1 2011+1.0%
Q4 2010-1.5%
Q3 2010+5.8%
Q3 2009+5.8%
Q4 2009+5.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro